Long-Term Evaluation of the Use of the Transdermal Contraceptive Patch in Adolescents
The transdermal contraceptive patch, Ortho Evra™, was approved in December 2001 and released on the market in June 2002. In this study, we reviewed clinical data of young women who started the patch between June 2002 and December 2003 in the adolescent medicine clinic at a university-based outpatien...
Saved in:
Main Authors: | Stephanie Logsdon, Jessica Richards, Hatim A. Omar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2004.107 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Profiles, Occurrence, and Management of Adolescent Patients with HAIR-AN Syndrome
by: Hatim A. Omar, et al.
Published: (2004-01-01) -
Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
by: Carmine D'Amico, et al.
Published: (2025-03-01) -
Bisoprolol Transdermal Patch Is Effective for the Treatment of AF Tachycardia
by: Yoh Arita, et al.
Published: (2018-01-01) -
Formulation and Evaluation of Galantamine Gel as Drug Reservoir in Transdermal Patch Delivery System
by: Woo Fong Yen, et al.
Published: (2015-01-01) -
Transdermal patches: Design and current approaches to painless drug delivery
by: Al Hanbali Othman A., et al.
Published: (2019-06-01)